Home » Topics » Regulatory » Patents

Patents
RSS

Abbott Laboratories and Enanta Pharmaceuticals present new HCV NS3 inhibitors

Jan. 11, 2012

Novel anti-inflammatory agents discovered in U.K.

Jan. 11, 2012

Roche prepares new series of phosphodiesterase 10A inhibitors

Jan. 11, 2012

Novel antibacterial agents patented by U.S. universities

Jan. 11, 2012

Novel serine/threonine-protein kinase PAK inhibitors designed

Jan. 10, 2012

New MAP kinase p38 inhibitors synthesized

Jan. 10, 2012

Scientists at Merck & Co. prepare new PRCP inhibitors

Jan. 10, 2012

AstraZeneca and Pulmagen Therapeutics patent novel compounds for respiratory disorders

Jan. 10, 2012

Novel estrogen receptor-alpha modulators prepared by Aragon Pharmaceuticals

Jan. 10, 2012

AstraZeneca patents new protein kinase inhibitors

Jan. 10, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026